Pharmaceuticals Subscribe

BMI View: Estonia’s healthcare system is much more mature than its Central and Eastern European peers, but given the country’s limited resources, the country is less appealing to pharmaceutical companies. Drugmakers can expect to see constrained revenue growth in the […]

BMI View: Despite the ongoing recovery in some high frequency indicators, subdued economic growth in France relative to regional peers will continue to weigh on the French government spending potential, posing downside risks to our pharmaceutical and healthcare sector forecasts. […]

BMI View: The Indonesian medical landscape will see a larger presence of private healthcare providers over medium term. Underpinning this expansion is the robust prospects for the industry, with the introduction of a Coordination of Benefits scheme allowing patients to […]

BMI View: Many emerging market economies are increasingly exposed to the negative effect of sustained lower commodity prices. This is putting downward pressure on government finances and, as a consequence, healthcare budgets. We nevertheless maintain a positive long-term outlook for […]

BMI View: With the recent oil strike representing a harbinger of significant political and economic turbulence ahead, the stability of its health and pharmaceutical sectors will depend on Kuwait’s integration with neighbouring Gulf states and international partners. Headline Expenditure Projections […]

BMI View: Drugmakers operating in Australia will face an increasingly challenging business environment as the Sixth Pharmacy Community Agreement’s measures come into effect. This includes a 5% price cut to medicines listed on the F1 formulary for more than five […]

BMI View: Although Cameroon’s economic growth is expected to remain on track driven by public-private partnerships in strategic infrastructure projects, the country’s pharmaceutical and healthcare sector will remain dependent on private out-of-pocket spending and global aid funds, which will weigh […]

BMI View: Chinese investment in Ecuador’s pharmaceutical and healthcare sector will continue to be pertinent for the country in order for it to meet the increasing demand of medicines within its public healthcare sector. Foreign generic drugmakers will, however, face […]

Migraine is a common neurovascular disorder that is characterized by throbbing headaches and is commonly associated with other neurological symptoms, such as nausea, vomiting, and painful sensitivity to lights and sounds. Migraines are thought to result from the activation and […]

This report Mainly covers the following product types Group A Meningitis Vaccine Group A&C Meningitis Vaccine The segment applications including Hospital use Clinic Epidemic Prevention Station Segment regions including (the separated region report can also be offered) USA China UK […]